TREM2-Transduced Myeloid Precursors Mediate Nervous Tissue Debris Clearance and Facilitate Recovery in an Animal Model of Multiple Sclerosis
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In multiple sclerosis, inflammation can successfully be prevented, while promoting repair is still a major challenge. Microglial cells, the resident phagocytes of the central nervous system (CNS), are hematopoietic-derived myeloid cells and express the triggering receptor expressed on myeloid cells 2 (TREM2), an innate immune receptor. Myeloid cells are an accessible source for ex vivo gene therapy. We investigated whether myeloid precursor cells genetically modified to express TREM2 affect the disease course of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis. METHODS AND FINDINGS: EAE was induced in mice by immunization with a myelin autoantigen. Intravenous application of TREM2-transduced bone marrow-derived myeloid precursor cells at the EAE peak led to an amelioration of clinical symptoms, reduction in axonal damage, and prevention of further demyelination. TREM2-transduced myeloid cells applied intravenously migrated into the inflammatory spinal cord lesions of EAE-diseased mice, showed increased lysosomal and phagocytic activity, cleared degenerated myelin, and created an anti-inflammatory cytokine milieu within the CNS. CONCLUSIONS: Intravenously applied bone marrow-derived and TREM2-tranduced myeloid precursor cells limit tissue destruction and facilitate repair within the murine CNS by clearance of cellular debris during EAE. TREM2 is a new attractive target for promotion of repair and resolution of inflammation in multiple sclerosis and other neuroinflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In particular, the clearance of myelin debris by microglia is believed to be critically required to limit neuronal damage in EAE (Cignarella et al., 2020; Takahashi et al., 2007; Weinger et al., 2011).”
From SYK coordinates neuroprotective microglial responses in neurodegenerative disease (2022) · cites this paper as Takahashi et al., 2007
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“TREM2 promotes proliferation (119), survival (119), and phagocytosis of apoptotic cells (120–122).”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [121]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552 · cited 1×
“Efficient removal of apoptotic cells and cellular debris by macrophages during acute injury or degenerative diseases is essential for repair of the damaged tissue, inflammation resolution, and disease recovery [11–13].”
BackgroundImmunosuppressive effects of apoptotic cells
Voll, R. E., Herrmann, M., Roth, E. A., Stach, C., Kalden, J. R., & Girkontaite, I. (1997) · Nature · doi:10.1038/37022 · Cited by 1,787 · cited 1×
“Efficient removal of apoptotic cells and cellular debris by macrophages during acute injury or degenerative diseases is essential for repair of the damaged tissue, inflammation resolution, and disease recovery [11–13].”
BackgroundA blast from the past: clearance of apoptotic cells regulates immune responses
Savill, J., Dransfield, I., Gregory, C., & Haslett, C. (2002) · Nature Reviews Immunology · doi:10.1038/nri957 · Cited by 1,574 · cited 1×
“Efficient removal of apoptotic cells and cellular debris by macrophages during acute injury or degenerative diseases is essential for repair of the damaged tissue, inflammation resolution, and disease recovery [11–13].”
BackgroundPerivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo
Hickey, W. F., & Kimura, H. (1988) · Science · doi:10.1126/science.3276004 · Cited by 1,466 · cited 1×
“Hematopoietic-derived myeloid cells physiologically migrate into the central nervous system (CNS) not only during development, but also in adulthood, and become resident perivascular macrophages and microglia [1–3].”
BackgroundTakahashi, K., Rochford, C. D. P., & Neumann, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041611 · Cited by 1,124 · cited 12×
“Recently, we discovered in vitro that the microglial triggering receptor expressed on myeloid cells-2 (TREM2) stimulates phagocytosis and down-regulates inflammatory signals in microglia via the signaling adaptor molecule DAP12 [14].”
BackgroundInfluentialSelf-citationYoussef, S., Stüve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L., et al. (2002) · Nature · doi:10.1038/nature01158 · Cited by 1,097 · cited 1×
“Most experimental approaches in EAE aim at skewing the cytokine profile of myelin-specific TH cells from TH1 to TH2 by altered peptide ligands [43,44], hydroxymethyl-glutaryl coenzyme A reductase inhibitors (‘‘statins’’) [45], or DNA vaccination combined with gene delivery of interleukin-4 (IL-4) [46].”
BackgroundInjection of adult neurospheres induces recovery in a chronic model of multiple sclerosis
Pluchino, S., Quattrini, A., Brambilla, E., Gritti, A., Salani, G., Dina, G., Galli, R., Del Carro, U., Amadio, S., Bergami, A., et al. (2003) · Nature · doi:10.1038/nature01552 · Cited by 1,068 · cited 1×
“Recently, brain-derived neurospheres have been injected intravenously and have been successfully used for cell therapy of EAE inducing repair and immunomodulatory activity [48,49], but these adult neural precursors are not a suitable cellular source for broad clinical applications.”
Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism
Pluchino, S., Zanotti, L., Rossi, B., Brambilla, E., Ottoboni, L., Salani, G., Martinello, M., Cattalini, A., Bergami, A., Furlan, R., et al. (2005) · Nature · doi:10.1038/nature03889 · Cited by 768
Experimental autoimmune encephalomyelitis repressed by microglial paralysis
Heppner, F. L., Greter, M., Marino, D., Falsig, J., Raivich, G., Hövelmeyer, N., Waisman, A., Rülicke, T., Prinz, M., Priller, J., et al. (2005) · Nature Medicine · doi:10.1038/nm1177 · Cited by 732 · cited 1×
“Furthermore, the microglial cytokine milieu determines the outcome of the inflammatory process in the animal model of MS, experimental autoimmune encephalomyelitis (EAE) [16–18].”
BackgroundSelf-citationTREMs in the immune system and beyond
Colonna, M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1106 · Cited by 701 · cited 2×
“dendritic cells, and microglia [21].”
Cited by
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Microglia Function in the Central Nervous System During Health and Neurodegeneration
Colonna, M., & Butovsky, O. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052358 · Cited by 2,894
Microglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858
“Neumann and colleagues (72) have shown that microglia express TREM2 (triggering receptor expressed on myeloid cells-2) and that this receptor is involved in the phagocytosis of debris and downregulation of proinflammatory cytokine expression.”
BackgroundTREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
Wang, Y., Cella, M., Mallinson, K., Ulrich, J. D., Young, K. L., Robinette, M. L., Gilfillan, S., Krishnan, G. M., Sudhakar, S., Zinselmeyer, B. H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.049 · Cited by 1,736
“Why is TREM2 activated during Aβ accumulation? Previous studies have indicated that TREM2 binds phospholipids, such as PS, and acts as a scavenger receptor for apoptotic cells that might be generated during neuronal damage (Hsieh et al., 2009; Takahashi et al., 2007; Takahashi et al., 2005).”
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease
Prinz, M., & Priller, J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3722 · Cited by 1,329
Self-citationDebris clearance by microglia: an essential link between degeneration and regeneration
Neumann, H., Kotter, M. R., & Franklin, R. J. M. (2008) · Brain · doi:10.1093/brain/awn109 · Cited by 1,111
“In addition to the high motility of their processes under normal conditions, they polarize and converge their processes at sites of brain injury attracted by extracellular ATP and mediated via microglial purinoreceptors (Davalos et al., 2005; Haynes et al., 2006).”
BackgroundSelf-citationMaternal immune activation and abnormal brain development across CNS disorders
Knuesel, I., Chicha, L., Britschgi, M., Schobel, S. A., Bodmer, M., Hellings, J. A., Toovey, S., & Prinssen, E. P. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.187 · Cited by 880
The role of peripheral immune cells in the CNS in steady state and disease
Prinz, M., & Priller, J. (2017) · Nature Neuroscience · doi:10.1038/nn.4475 · Cited by 657
Self-citationInefficient clearance of myelin debris by microglia impairs remyelinating processes
Lampron, A., Larochelle, A., Laflamme, N., Préfontaine, P., Plante, M.-M., Sánchez, M. G., Yong, V. W., Stys, P. K., Tremblay, M.-È., & Rivest, S. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141656 · Cited by 595
“Apoptotic neurons are phagocytized without inflammation via receptors like TREM-2 (Takahashi et al., 2005), which is also implicated in myelin removal during EAE (Piccio et al., 2007; Takahashi et al., 2007).”
BackgroundJanus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis
Sierra, A., Abiega, O., Shahraz, A., & Neumann, H. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00006 · Cited by 574
“Enhancing brain phagocytosis via intravenous delivery of TREM2-transduced bone marrow-derived precursor cells potentiates the clearance of degenerated myelin, decreases the inflammatory response and ameliorates the course of the disease in the mouse model of multiple sclerosis (MS), experimental acute encephalomyeliti…”
BackgroundInfluentialSelf-citationTREM2 sustains microglial expansion during aging and response to demyelination
Poliani, P. L., Wang, Y., Fontana, E., Robinette, M. L., Yamanishi, Y., Gilfillan, S., & Colonna, M. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77983 · Cited by 525
“Moreover, an in vivo study showed that intravenous injection of bone marrow–derived myeloid cells overexpressing TREM2 during experimental autoimmune encephalomyelitis, a model of immune-mediated demyelination, curbed disease by promoting the clearance of apoptotic neurons and secretion of IL-10 (22).”
New insights into the role of TREM2 in Alzheimer’s disease
Gratuze, M., Leyns, C. E. G., & Holtzman, D. M. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0298-9 · Cited by 489
Comparison of polarization properties of human adult microglia and blood‐derived macrophages
Durafourt, B. A., Moore, C. S., Zammit, D. A., Johnson, T. A., Zaguia, F., Guiot, M., Bar‐Or, A., & Antel, J. P. (2012) · Glia · doi:10.1002/glia.22298 · Cited by 477
“In the context of MS, myelin debris has been shown to inhibit remyelination (Kotter et al., 2006), while debris clearance by myeloid cells has been shown to promote repair in EAE (Takahashi et al., 2007).”
BackgroundInfluentialA role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia
Hsieh, C. L., Koike, M., Spusta, S. C., Niemi, E. C., Yenari, M., Nakamura, M. C., & Seaman, W. E. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06042.x · Cited by 475
“In mice with experimental autoimmune encephalitis (EAE), blockade of TREM2 with a mAb exacerbates disease, while treatment with TREM2-expressing myeloid cells reduces inflammation and improves disease (Piccio et al. 2007; Takahashi et al. 2007).”
BackgroundTREM2, microglia, and neurodegenerative diseases
Yeh, F. L., Hansen, D. V., & Sheng, M. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.03.008 · Cited by 440
“Specifically, TREM2-overexpressing cells helped to limit axonal damage as well as demyelination within the spinal cord [116].”
BackgroundInfluentialAn Inflammation-Centric View of Neurological Disease: Beyond the Neuron
Skaper, S. D., Facci, L., Zusso, M., & Giusti, P. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00072 · Cited by 457
“, 2013) and facilitates nervous tissue debris clearance (Takahashi et al., 2007).”
BackgroundType II monocytes modulate T cell–mediated central nervous system autoimmune disease
Weber, M. S., Prod'homme, T., Youssef, S., Dunn, S. E., Rundle, C. D., Lee, L., Patarroyo, J. C., Stüve, O., Sobel, R. A., Steinman, L., et al. (2007) · Nature Medicine · doi:10.1038/nm1620 · Cited by 447
Mildner, A., Mack, M., Schmidt, H., Brück, W., Djukic, M., Zabel, M. D., Hille, A., Priller, J., & Prinz, M. (2009) · Brain · doi:10.1093/brain/awp144 · Cited by 445
Self-citationTREM and TREM-like receptors in inflammation and disease
Ford, J. W., & McVicar, D. W. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.01.009 · Cited by 434
Roles of microglia in brain development, tissue maintenance and repair
Michell-Robinson, M. A., Touil, H., Healy, L. M., Owen, D. R., Durafourt, B. A., Bar-Or, A., Antel, J. P., & Moore, C. S. (2015) · Brain · doi:10.1093/brain/awv066 · Cited by 425
TREM2 in Neurodegenerative Diseases
Jay, T. R., von Saucken, V. E., & Landreth, G. E. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0197-5 · Cited by 427
“Outside of AD, TREM2 is important for clearance of myelin in experimental autoimmune encephalomyelitis (EAE) [159] and peri-infarct tissue in mice following MCAO [160].”
BackgroundInfluentialTREM2 variants: new keys to decipher Alzheimer disease pathogenesis
Colonna, M., & Wang, Y. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.7 · Cited by 418
Chen, S., Peng, J., Sherchan, P., Ma, Y., Xiang, S., Yan, F., Zhao, H., Jiang, Y., Wang, N., Zhang, J. H., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01853-x · Cited by 379
“Numerous studies have revealed that TREM2 exerts anti-inflammatory properties and promotes phagocytosis of apoptotic neuronal cells in neurodegenerative diseases, liver ischemia/reperfusion injury, and bacterial infections [20, 21, 32, 43, 44].”
Kawabori, M., Kacimi, R., Kauppinen, T., Calosing, C., Kim, J. Y., Hsieh, C. L., Nakamura, M. C., & Yenari, M. A. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2620-14.2015 · Cited by 375
“…work identified microglia as the major brain cells expressing the highest levels of TREM2, (Schmid et al., 2002; Sessa et al., 2004), and TREM2 mediates microglial phagocytosis of apoptotic neurons in various neurological diseases (Takahashi et al., 2007; Hsieh et al., 2009; Neumann et al., 2009).”
BackgroundFactors regulating microglia activation
Kierdorf, K., & Prinz, M. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00044 · Cited by 360
“In addition, another study reported that CX3CR1-deficient animals exhibited an inhibition in microglial recruitment to forming synapses in the barrel field of the somatosensory cortex, leading to an abnormal synapse formation in this area (Hoshiko et al., 2012).”
BackgroundSelf-citationSYK coordinates neuroprotective microglial responses in neurodegenerative disease
Ennerfelt, H., Frost, E. L., Shapiro, D. A., Holliday, C., Zengeler, K. E., Voithofer, G., Bolte, A. C., Lammert, C. R., Kulas, J. A., Ulland, T. K., et al. (2022) · Cell · doi:10.1016/j.cell.2022.09.030 · Cited by 297
“Experimental autoimmune encephalomyelitis (EAE) induction and scoring—”
InfluentialJiang, T., Tan, L., Zhu, X.-C., Zhang, Q.-Q., Cao, L., Tan, M.-S., Gu, L.-Z., Wang, H.-F., Ding, Z.-Z., Zhang, Y.-D., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.164 · Cited by 320
Microglial clearance function in health and disease
Napoli, I., & Neumann, H. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.046 · Cited by 313
Self-citationCoding variants in TREM2 increase risk for Alzheimer's disease
Jin, S. C., Benitez, B. A., Karch, C. M., Cooper, B., Skorupa, T., Carrell, D., Norton, J. B., Hsu, S., Harari, O., Cai, Y., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu277 · Cited by 314
Immune Modulation of Stem Cells and Regeneration
Aurora, A. B., & Olson, E. N. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.06.009 · Cited by 308
“These findings shed light on the paradox raised by previous data that upon injury, blocking CCR2 can be cardioprotective while depleting macrophages by other strategies further increases injury and hampers cardiac function (Kaikita et al., 2004; van Amerongen et al., 2007).”
BackgroundPiccio, L., Buonsanti, C., Cella, M., Tassi, I., Schmidt, R. E., Fenoglio, C., Rinker, J., Naismith, R. T., Panina-Bordignon, P., Passini, N., et al. (2008) · Brain · doi:10.1093/brain/awn217 · Cited by 307
“Furthermore, two different studies have reported a protective role of TREM-2 in the animal model for multiple sclerosis (Piccio et al., 2007; Takahashi et al., 2007).”
BackgroundPhagocytosis in the Brain: Homeostasis and Disease
Galloway, D. A., Phillips, A. E. M., Owen, D. R. J., & Moore, C. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00790 · Cited by 307
Devanney, N. A., Stewart, A. N., & Gensel, J. C. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113310 · Cited by 306
“TREM2 is expressed by microglia and plays a crucial role in maintaining normal CNS function (Hsieh et al., 2009; Takahashi et al., 2007).”
BackgroundThe Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E
Bailey, C. C., DeVaux, L. B., & Farzan, M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.677286 · Cited by 303
“A few investigations have also shown a role for TREM2 in recognizing or promoting clearance of apoptotic bodies or cellular debris (31, 32, 38).”
BackgroundMicroglial TREM2/DAP12 signaling: a double-edged sword in neural diseases
Konishi, H., & Kiyama, H. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00206 · Cited by 300
TREM2 regulates microglial cell activation in response to demyelination in vivo
Cantoni, C., Bollman, B., Licastro, D., Xie, M., Mikesell, R., Schmidt, R., Yuede, C. M., Galimberti, D., Olivecrona, G., Klein, R. S., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1388-1 · Cited by 296
“We and others have previously shown a protective role for TREM2 in an animal model for multiple sclerosis, experimental autoimmune encephalomyelitis, in which TREM2 expression was preferentially expressed by resident microglia [63, 78].”
Pierigè, F., Serafini, S., Rossi, L., & Magnani, M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.029 · Cited by 295
Microglia actions in Alzheimer's disease
Prokop, S., Miller, K. R., & Heppner, F. L. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1182-x · Cited by 291
“Specifically, TREM2 has been shown to influence several aspects of microglia activity including motility, T cell interactions, cytokine production and phagocytosis [65, 97, 144, 145].”
BackgroundKierdorf, K., & Prinz, M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90602 · Cited by 285
“DAP12 and its receptor, triggering receptor expressed on myeloid cells 2 (TREM2), have been shown to induce removal of apoptotic neurons in vitro and indicate that microglia play a critical role in eliminating apoptotic neurons during development without inducing an inflammatory phenotype (49, 50).”
BackgroundSelf-citationEfficient colonic mucosal wound repair requires Trem2 signaling
Seno, H., Miyoshi, H., Brown, S. L., Geske, M. J., Colonna, M., & Stappenbeck, T. S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803343106 · Cited by 284
Can the immune system be harnessed to repair the CNS?
Popovich, P. G., & Longbrake, E. E. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2398 · Cited by 284
“Similarly, ex vivo gene transfection of myeloid precursors or bone marrow cells could ameliorate or alter the course of neurological diseas”
BackgroundTREM2-Ligand Interactions in Health and Disease
Kober, D. L., & Brett, T. J. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.04.004 · Cited by 284
Macrophage subsets and microglia in multiple sclerosis
Bogie, J. F. J., Stinissen, P., & Hendriks, J. J. A. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1310-2 · Cited by 251
Clearance of cerebral Aβ in Alzheimer’s disease: reassessing the role of microglia and monocytes
Zuroff, L., Daley, D., Black, K. L., & Koronyo-Hamaoui, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2463-7 · Cited by 275
The multifaceted profile of activated microglia
Lynch, M. A. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8077-9 · Cited by 268
“In EAE, beneficial effects were observed in mice treated with bone-marrow-derived and TREM-2-tranduced myeloid precursor cells; in these animals, there was evidence of a reduction in tissue destruction and increased clearance of cell debris [162].”
BackgroundLowell, C. A. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002352 · Cited by 266
“In macrophages, this inhibitory signaling may be mediated through TREM-2, which is a DAP12 coupled receptor thought to be involved in recognition of various bacterial structures and potentially apoptotic cells (Hamerman et al. 2006; Takahashi et al. 2007; Hsieh et al. 2009; N’Diaye et al. 2009).”
BackgroundMicroglia in the developing brain: a potential target with lifetime effects
Harry, G. J., & Kraft, A. D. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.01.012 · Cited by 250
“Given that TREM2 functions to inhibit microglial and macrophage cytokine expression and promotes microglial phagocytosis of cellular debris (Takahashi et al., 2007), it is possible that the close apposition of TREM2+/DAP12+ microglia to oligodendrocytes prior to myelination represents a regulatory…”
The role of microglia and myeloid immune cells in acute cerebral ischemia
Benakis, C., Garcia-Bonilla, L., Iadecola, C., & Anrather, J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00461 · Cited by 248
TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice
Frank, S., Burbach, G. J., Bonin, M., Walter, M., Streit, W., Bechmann, I., & Deller, T. (2008) · Glia · doi:10.1002/glia.20710 · Cited by 247
“An example of its immune regulatory function is evident in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis: In this setting intravenously applied TREM2transduced bone-marrow derived myeloid cells ameliorated clinical symptoms by migration into the inflamed spinal cord, subsequent…”
BackgroundResultInfluentialA distinct population of microglia supports adult neurogenesis in the subventricular zone
Ribeiro Xavier, A. L., Kress, B. T., Goldman, S. A., Lacerda de Menezes, J. R., & Nedergaard, M. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.1217-15.2015 · Cited by 225
“Interestingly, CX3CR1-EGFP cells of the SVZ and RMS do not express TREM2 (triggering receptor expressed on myeloid cells 2), a receptor involved in the activation of microglial phagocytosis (Takahashi et al., 2005; Takahashi et al., 2007; Linnartz and Neumann, 2013; Fig.”
BackgroundNatrajan, M. S., de la Fuente, A. G., Crawford, A. H., Linehan, E., Nuñez, V., Johnson, K. R., Wu, T., Fitzgerald, D. C., Ricote, M., Bielekova, B., et al. (2015) · Brain · doi:10.1093/brain/awv289 · Cited by 218
TREM2, microglia, and Alzheimer’s disease.
Qin, Q., Teng, Z., Liu, C., Li, Q., Yin, Y., & Tang, Y. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111438 · Cited by 219
TREM-2 promotes macrophage survival and lung disease after respiratory viral infection
Wu, K., Byers, D. E., Jin, X., Agapov, E., Alexander-Brett, J., Patel, A. C., Cella, M., Gilfilan, S., Colonna, M., Kober, D. L., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141732 · Cited by 207
“This type of were thought to be proinflammatory and destructive in models of intestinal and CNS disease (Schenk et al., 2007; Takahashi et al., 2007; Seno et al., 2009).”
BackgroundLi, R.-Y., Qin, Q., Yang, H.-C., Wang, Y.-Y., Mi, Y.-X., Yin, Y.-S., Wang, M., Yu, C.-J., & Tang, Y. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00542-y · Cited by 204
Linker, R. A., Lee, D.-H., Demir, S., Wiese, S., Kruse, N., Siglienti, I., Gerhardt, E., Neumann, H., Sendtner, M., Luhder, F., et al. (2010) · Brain · doi:10.1093/brain/awq179 · Cited by 202
“…freshly prepared T cells (purified via magnetic beads, Miltenyi), peritoneal macrophages (prepared as described in Linker et al., 2008), microglia or astrocytes [prepared as described in Magnus et al. (2002) and Takahashi et al. (2007)] was purified over RNeasy columns (Qiagen, Hilden, Germany).”
MethodSelf-citationVoß, E. V., Škuljec, J., Gudi, V., Skripuletz, T., Pul, R., Trebst, C., & Stangel, M. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.09.008 · Cited by 202
“In EAE antibody-mediated blockade of TREM-2 during the effector phase results in exacerbation of disease (Piccio et al., 2007) and the intravenous application of TREM-2-transduced myeloid cells leads to amelioration of EAE associated with increased myelin phagocytosis (Takahashi et al., 2007).”
BackgroundRole of Microglia in CNS Autoimmunity
Goldmann, T., & Prinz, M. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/208093 · Cited by 196
“Virus-mediated overexpression of TREM2 in myeloid cells increased the clearance of myelin debris, thereby improving the tissue regeneration and consequently reducing the severity of clinical symptoms [75].”
Self-citationYang, J., Jiang, Z., Fitzgerald, D. C., Ma, C., Yu, S., Li, H., Zhao, Z., Li, Y., Ciric, B., Curtis, M., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37914 · Cited by 194
RetractedWang, E. C. E., Dai, Z., Ferrante, A. W., Drake, C. G., & Christiano, A. M. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.01.011 · Cited by 182
Dong, Y., D’Mello, C., Pinsky, W., Lozinski, B. M., Kaushik, D. K., Ghorbani, S., Moezzi, D., Brown, D., Melo, F. C., Zandee, S., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00801-z · Cited by 181
Macrophage phagocytosis after spinal cord injury: when friends become foes
Van Broeckhoven, J., Sommer, D., Dooley, D., Hendrix, S., & Franssen, A. J. P. M. (2021) · Brain · doi:10.1093/brain/awab250 · Cited by 172
Landel, V., Baranger, K., Virard, I., Loriod, B., Khrestchatisky, M., Rivera, S., Benech, P., & Féron, F. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-33 · Cited by 176
“The first of these pathways couples increases in Trem2 expression on microglia with enhanced phagocytosis [143-145].”
TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice
Jiang, T., Zhang, Y.-D., Chen, Q., Gao, Q., Zhu, X.-C., Zhou, J.-S., Shi, J.-Q., Lu, H., Tan, L., & Yu, J.-T. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.01.028 · Cited by 176
Dower, K., Ellis, D. K., Saraf, K., Jelinsky, S. A., & Lin, L.-L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3520 · Cited by 175
“Indeed, in microglial cells TREM-2 promotes phagocytosis while suppressing proinflammatory cytokine production (32), and TREM-2 expression dampens inflammation in mouse models of multiple sclerosis (8, 33).”
BackgroundProtective effects of microglia in multiple sclerosis
Napoli, I., & Neumann, H. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.04.024 · Cited by 175
“Recently, a beneficial role of the microglial phagocytic triggering receptor expressed on myeloid cells-2 (TREM2) receptors has also been demonstrated in EAE (Piccio et al., 2007; Takahashi et al., 2007).”
BackgroundSelf-citationTREM2 in CNS homeostasis and neurodegenerative disease
Painter, M. M., Atagi, Y., Liu, C.-C., Rademakers, R., Xu, H., Fryer, J. D., & Bu, G. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0040-9 · Cited by 169
Wes, P. D., Holtman, I. R., Boddeke, E. W. G. M., Möller, T., & Eggen, B. J. L. (2016) · Glia · doi:10.1002/glia.22866 · Cited by 167
Genetics ignite focus on microglial inflammation in Alzheimer’s disease
Malik, M., Parikh, I., Vasquez, J. B., Smith, C., Tai, L., Bu, G., LaDu, M. J., Fardo, D. W., Rebeck, G. W., & Estus, S. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0048-1 · Cited by 161
“Consistent with this possibility, TREM2transduced macrophages promote clearance of neuronal debris and recovery in an animal model of multiple sclerosis [56].”
BackgroundGenetics of Alzheimer's Disease
Guerreiro, R., & Hardy, J. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0295-9 · Cited by 155
Lue, L., Schmitz, C. T., Serrano, G., Sue, L. I., Beach, T. G., & Walker, D. G. (2015) · Brain Pathology · doi:10.1111/bpa.12190 · Cited by 154
“This has been supported by the evidence from animal models of multiple sclerosis (37, 45).”
ResultTREM2 Function in Alzheimer’s Disease and Neurodegeneration
Ulrich, J. D., & Holtzman, D. M. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00313 · Cited by 154
Schmid, C. D., Melchior, B., Masek, K., Puntambekar, S. S., Danielson, P. E., Lo, D. D., Gregor Sutcliffe, J., & Carson, M. J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05984.x · Cited by 152
“C1qA and Trem2, two of the three molecules identified by qPCR as being enriched in adult microglia isolated from inflamed adult CNS (Table 1), are known to be expressed by microglia (Schmid et al. 2002; Takahasi et al. 2007; Farber et al. 2009; Thrash et al. 2009).”
TREM2 protects against cerebral ischemia/reperfusion injury
Wu, R., Li, X., Xu, P., Huang, L., Cheng, J., Huang, X., Jiang, J., Wu, L.-J., & Tang, Y. (2017) · Molecular Brain · doi:10.1186/s13041-017-0296-9 · Cited by 153
The surface‐exposed chaperone, Hsp60, is an agonist of the microglial TREM2 receptor
Stefano, L., Racchetti, G., Bianco, F., Passini, N., Gupta, R. S., Bordignon, P. P., & Meldolesi, J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06130.x · Cited by 152
“In addition, blockade of the receptor was shown to exacerbate brain pathology, and intravenous application of TREM2rich stem cells to facilitate brain repair in experimental autoimmune encephalomyelitis, the animal model of multiple sclerosis (Piccio et al. 2007; Takahashi et al. 2007).”
BackgroundTREM2 modulates microglia phenotypes in the neuroinflammation of Parkinson's disease
Zhang, Y., Feng, S., Nie, K., Li, Y., Gao, Y., Gan, R., Wang, L., Li, B., Sun, X., Wang, L., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.03.226 · Cited by 161
The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis
Mallucci, G., Peruzzotti-Jametti, L., Bernstock, J. D., & Pluchino, S. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.02.003 · Cited by 145
“The presence of microglia/macrophages in every step of the evolving GM lesion suggests a role for mononuclear cells in clearing the environment of growth inhibitory molecules (Piccio et al., 2007; Takahashi et al., 2007).”
Role of microglia in neuronal degeneration and regeneration
Walter, L. M., & Neumann, H. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0180-5 · Cited by 167
“Bone marrow-derived myeloid precursors lentivirally transduced with TREM2 (TREM2+ BM-MC) were shown to resolve inflammation in the CNS [71].”
BackgroundSelf-citationPohl, H. B. F., Porcheri, C., Mueggler, T., Bachmann, L. C., Martino, G., Riethmacher, D., Franklin, R. J. M., Rudin, M., & Suter, U. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5035-10.2011 · Cited by 145
Non-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damage
Perugorria, M. J., Esparza-Baquer, A., Oakley, F., Labiano, I., Korosec, A., Jais, A., Mann, J., Tiniakos, D., Santos-Laso, A., Arbelaiz, A., et al. (2019) · Gut · doi:10.1136/gutjnl-2017-314107 · Cited by 144
“16 Our work suggests that TREM-2 could be an attractive target for promoting the resolution of inflammation during liver injury and for the prevention of parenchymal cell death, this akin to events described for TREM-2 in neuro-inflammatory diseases and sepsis.(16) 49”
BackgroundPharmacological Targeting of Microglial Activation: New Therapeutic Approach
Liu, C.-Y., Wang, X., Liu, C., & Zhang, H.-L. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00514 · Cited by 142
Yan, J., Zhang, Y., Wang, L., Zhao, L., Tang, S., Wang, Y., Gu, N., Sun, X., & Li, L. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02651-3 · Cited by 157
“Research has demonstrated that TREM2 limits tissue destruction and facilitates repair within the CNS by clearing cellular debris during experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis [22].”
BackgroundKopper, T. J., & Gensel, J. C. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24114 · Cited by 138
“In an experimental model of MS, TREM2 facilitated myelin removal while increasing anti-inflammatory cytokine production (Takahashi et al., 2007).”
Macrophage signaling in HIV-1 infection
Herbein, G., Gras, G. S., Khan, K. A., & Abbas, W. (2010) · Retrovirology · doi:10.1186/1742-4690-7-34 · Cited by 157
Melchior, B., Garcia, A. E., Hsiung, B.-K., Lo, K. M., Doose, J. M., Thrash, J. C., Stalder, A. K., Staufenbiel, M., Neumann, H., & Carson, M. J. (2010) · ASN Neuro · doi:10.1042/an20100010 · Cited by 134
Self-citationAlzheimer's Disease: The Role of Microglia in Brain Homeostasis and Proteopathy
Clayton, K. A., Van Enoo, A. A., & Ikezu, T. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00680 · Cited by 134
“, 2012), whereas triggering receptor expressed on myeloid cells 2 (TREM2), is known to control microglia-mediated Aβ compaction, and phagocytosis of apoptotic neurons (Piccio et al., 2007; Takahashi et al., 2007; Yuan et al., 2016).”
BackgroundSoluble TREM2: Innocent bystander or active player in neurological diseases?
Filipello, F., Goldsbury, C., You, S. F., Locca, A., Karch, C. M., & Piccio, L. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105630 · Cited by 134
Zhong, L., Chen, X.-F., Zhang, Z.-L., Wang, Z., Shi, X.-Z., Xu, K., Zhang, Y.-W., Xu, H., & Bu, G. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.645986 · Cited by 133
“Previous studies have demonstrated that TREM2 negatively regulates Toll-like receptor-induced inflammatory cytokine production (11, 12, 31).”
BackgroundNeuroinflammation, Mast Cells, and Glia: Dangerous Liaisons
Skaper, S. D., Facci, L., Zusso, M., & Giusti, P. (2017) · The Neuroscientist · doi:10.1177/1073858416687249 · Cited by 138
Griffiths, M. R., Gasque, P., & Neal, J. W. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181996688 · Cited by 130
“Moreover, intravenous administration of TREM-2 in bone marrow precursor cells in vivo was accompanied by downregulation of TNF, increased interleukin 10 expression, and greater clearance of myelin debris; these had the effect of reducing the severity of EAE (59).”
BackgroundSieber, M. W., Jaenisch, N., Brehm, M., Guenther, M., Linnartz-Gerlach, B., Neumann, H., Witte, O. W., & Frahm, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052982 · Cited by 130
Self-citationThe expanding roles of ITAM adapters FcRγ and DAP12 in myeloid cells
Hamerman, J. A., Ni, M., Killebrew, J. R., Chu, C., & Lowell, C. A. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00841.x · Cited by 129
“Recently, two papers have highlighted the inhibitory role of TREM-2 in vivo in the CNS disease experimental autoimmune encephalomyelitis (EAE), a mouse model for human multiple sclerosis (95, 96).”
BackgroundResultMicroglia: unique and common features with other tissue macrophages
Prinz, M., Tay, T. L., Wolf, Y., & Jung, S. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1267-1 · Cited by 126
“It plays a role in suppressing the synthesis of pro-inflammatory factors [45, 132] and promotes protective phagocytosis of cellular debris, such as degenerated myelin, as demonstrated in an animal model of MS [128].”
BackgroundSelf-citationTeter, B., Morihara, T., Lim, G. P., Chu, T., Jones, M. R., Zuo, X., Paul, R. M., Frautschy, S. A., & Cole, G. M. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.02.015 · Cited by 124
“, 2012), promoting pro-phagocytic and anti-inflammatory activities (Painter et al., 2015; Takahashi et al., 2007) in amyloid plaque-associated microglia (Frank et al.”
BackgroundMoliné‐Velázquez, V., Cuervo, H., Vila‐del Sol, V., Ortega, M. C., Clemente, D., & de Castro, F. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00495.x · Cited by 124
“Intravenously applied myeloid precursors transduced with microglial TREM2 (triggering receptor expressed on myeloid cells-2) ameliorate clinical symptoms and induce recovery from EAE (47).”
BackgroundTREM2 regulates microglial lipid droplet formation and represses post-ischemic brain injury
Wei, W., Zhang, L., Xin, W., Pan, Y., Tatenhorst, L., Hao, Z., Gerner, S. T., Huber, S., Juenemann, M., Butz, M., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115962 · Cited by 122
Ren, M., Guo, Y., Wei, X., Yan, S., Qin, Y., Zhang, X., Jiang, F., & Lou, H. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.01.016 · Cited by 126
“upstream of the NF-κB inflammatory signaling pathways and has been shown to be negatively regulated by TREM2 in other experimental models (Ito and Hamerman, 2012; Takahashi et al., 2007; Turnbull et al., 2006).”
Phagocyte dysfunction, tissue aging and degeneration
Li, W. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.05.006 · Cited by 118
Jiang, T., Tan, L., Zhu, X.-C., Zhou, J.-S., Cao, L., Tan, M.-S., Wang, H.-F., Chen, Q., Zhang, Y.-D., & Yu, J.-T. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.08.019 · Cited by 111
Jiang, T., Yu, J., Zhu, X., & Tan, L. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8424-8 · Cited by 131
“In animal models of multiple sclerosis and autoimmune encephalomyelitis, increased expression of TREM2 on microglia was coupled to enhance phagocytic pathways and promote the M2-like activation state of microglia, which was thought to has protective effects [37, 38].”
BackgroundIFNβ secreted by microglia mediates clearance of myelin debris in CNS autoimmunity
Kocur, M., Schneider, R., Pulm, A.-K., Bauer, J., Kropp, S., Gliem, M., Ingwersen, J., Goebels, N., Alferink, J., Prozorovski, T., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0192-4 · Cited by 115
Metadata
- Authors
- Takahashi, K., Prinz, M., Stagi, M., Chechneva, O., & Neumann, H.
- Affiliations
- University of Bonn (DE)
- Universitätsmedizin Göttingen (DE)
- Corresponding author
- Neumann, Harald
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-04-10
- Volume
- 4
- Issue
- 4
- Pages
- e124
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC1851623
- OpenAlex
- W2116226263
- Cited by
- 414
- References
- 51
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 28 · 2023: 18 · 2022: 19 · 2021: 22 · 2020: 19 · 2019: 23 · 2018: 23 · 2017: 28 · 2016: 24 · 2015: 35 · 2014: 32 · 2013: 34 · 2012: 16
- FWCI
- 13.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
- Funders
- Deutsche Forschungsgemeinschaft (SFB 704)
- Gemeinnützige Hertie-Stiftung
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- TREM2, multiple sclerosis, experimental autoimmune encephalomyelitis, myeloid precursors, microglia, phagocytosis, myelin debris clearance, demyelination, axonal injury, neuroinflammation, neurorepair, gene therapy, bone marrow-derived cells, anti-inflammatory cytokines
- MeSH terms
- Animals, Cell Differentiation, Cell Movement, Cells, Cultured, Disease Models, Animal, Encephalomyelitis, Autoimmune, Experimental, Female, Flow Cytometry, Gene Expression Regulation, Genes, Synthetic, Genetic Vectors, Humans, Membrane Glycoproteins, Mice, Inbred C57BL, Monocytes, Multiple Sclerosis, Neurons, Phagocytosis, Promoter Regions, Genetic, Receptors, Immunologic, Transduction, Genetic, Genetic Therapy, Lentivirus, Granulocyte-Macrophage Colony-Stimulating Factor, Cytokines, Interleukin-10, Apoptosis, Microglia, Genes, Reporter, Hematopoietic Stem Cell Transplantation, Cell Lineage, Myeloid Cells, Mice, Nitric Oxide Synthase Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.